Article Information
History
- September 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Josephine Q.N. Nguyen1,2,
- Wojtek Drabarek3,
- Aïsha M.C.H.J. Leeflang1,2,
- Tom Brands1,2,
- Thierry P.P. van den Bosch4,
- Robert M. Verdijk3,4,5,
- Harmen J.G. van de Werken6,7,8,
- Job van Riet6,7,
- Dion Paridaens1,3,
- Annelies de Klein2,
- Erwin Brosens2,*,#,
- Emine Kiliç1,*,# and
- Rotterdam Ocular Melanoma Study group
- 1Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- 2Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- 3The Rotterdam Eye Hospital, 3011 BH Rotterdam, The Netherlands
- 4Department of Pathology, Section Ophthalmic Pathology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- 5Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
- 6Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- 7Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- 8Department of Immunology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
- ↵#Correspondence: e.brosens{at}erasmusmc.nl; e.kilic{at}erasmusmc.nl; Tel.: +31107030683
↵* These authors contributed equally to this work.
Posted September 23, 2022.
